New nanoparticle can help detect cancer at early stages

01/23/2008 | Examiner (Washington, D.C.), The

Researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine have developed nanoparticles that help preserve biomarkers, which can indicate cancer and other diseases, a step that could lead to cancer detection at much earlier stages. Different biomarkers can be tested by altering the nanoparticles.

View Full Article in:

Examiner (Washington, D.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT